Corcept Therapeutics (CORT) News Today $78.69 -0.78 (-0.98%) Closing price 10/17/2025 04:00 PM EasternExtended Trading$78.40 -0.30 (-0.37%) As of 10/17/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CORT Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Mutual of America Capital Management LLC Lowers Position in Corcept Therapeutics Incorporated $CORT1 hour ago | marketbeat.comNew York State Teachers Retirement System Raises Stake in Corcept Therapeutics Incorporated $CORT1 hour ago | marketbeat.comCorcept Therapeutics Incorporated $CORT Shares Sold by US Bancorp DE1 hour ago | marketbeat.comCorcept Presents ESMO 2025 Late-Breaker: Relacorilant Demonstrates Benefit in Patients with Platinum-Resistant Ovarian Cancer with Prior PARP Inhibitor TreatmentOctober 19 at 5:15 AM | businesswire.comCorcept Therapeutics Incorporated $CORT Stake Raised by Envestnet Portfolio Solutions Inc.October 19 at 3:52 AM | marketbeat.comAllspring Global Investments Holdings LLC Reduces Stake in Corcept Therapeutics Incorporated $CORTOctober 18 at 3:55 AM | marketbeat.comCorcept Therapeutics (NASDAQ:CORT) Rating Lowered to Hold at Wall Street ZenOctober 18 at 2:36 AM | marketbeat.comDaniel Swisher Jr Sells 2,200 Shares of Corcept Therapeutics (NASDAQ:CORT) StockOctober 16, 2025 | marketbeat.comCorcept Therapeutics (NASDAQ:CORT) Shares Up 7.9% - Here's What HappenedOctober 16, 2025 | marketbeat.comDaniel Swisher, Jr. Sells 2,200 Shares of Corcept Therapeutics (NASDAQ:CORT) StockOctober 16, 2025 | insidertrades.comTD Asset Management Inc Purchases Shares of 819,882 Corcept Therapeutics Incorporated $CORTOctober 16, 2025 | marketbeat.comCorcept (CORT) Shares Skyrocket, What You Need To KnowOctober 15, 2025 | finance.yahoo.comCorcept: Transition To New Specialty Pharmacy Well UnderwayOctober 15, 2025 | seekingalpha.comBoston Trust Walden Corp Has $41.99 Million Stock Holdings in Corcept Therapeutics Incorporated $CORTOctober 15, 2025 | marketbeat.comCorcept Submits Marketing Authorization Application to European Medicines Agency for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian CancerOctober 14, 2025 | finance.yahoo.comCorcept Therapeutics Ends Distribution Agreement with OptimeOctober 14, 2025 | tipranks.comCorcept Therapeutics Incorporated $CORT Holdings Trimmed by Aberdeen Group plcOctober 14, 2025 | marketbeat.comKLP Kapitalforvaltning AS Reduces Position in Corcept Therapeutics Incorporated $CORTOctober 14, 2025 | marketbeat.comCorcept Therapeutics (CORT) Is Down 16.1% After Distribution Shift and Insider Selling—What's ChangedOctober 13, 2025 | finance.yahoo.comCorcept Therapeutics Incorporated $CORT Shares Sold by Mitchell Capital Management Co.October 13, 2025 | marketbeat.comCorcept Therapeutics' (CORT) Buy Rating Reiterated at HC WainwrightOctober 13, 2025 | americanbankingnews.comTruist Financial Remains a Buy on Corcept Therapeutics (CORT)October 11, 2025 | theglobeandmail.comCorcept Therapeutics (CORT) Receives a Buy from H.C. WainwrightOctober 11, 2025 | theglobeandmail.comCorcept Therapeutics (NASDAQ:CORT) Earns "Buy" Rating from HC WainwrightOctober 11, 2025 | marketbeat.comMaryland State Retirement & Pension System Has $2.37 Million Stock Position in Corcept Therapeutics Incorporated $CORTOctober 11, 2025 | marketbeat.comCorcept Therapeutics (NASDAQ:CORT) Insider William Guyer Sells 20,000 SharesOctober 10, 2025 | marketbeat.comHC Wainwright & Co. Reiterates Corcept Therapeutics (CORT) Buy RecommendationOctober 10, 2025 | msn.comWhy Corcept (CORT) Shares Are Falling TodayOctober 10, 2025 | msn.comInsider Selling: Corcept Therapeutics (NASDAQ:CORT) Insider Sells 20,000 Shares of StockOctober 10, 2025 | insidertrades.comCorcept Therapeutics' (CORT) "Hold (C)" Rating Reiterated at Weiss RatingsOctober 9, 2025 | marketbeat.comCorcept Therapeutics (NASDAQ:CORT) Stock Price Down 4.9% - Here's WhyOctober 8, 2025 | marketbeat.comCorcept Therapeutics Board Member Resigns, Continues as ConsultantOctober 7, 2025 | msn.comQRG Capital Management Inc. Acquires 13,829 Shares of Corcept Therapeutics Incorporated $CORTOctober 6, 2025 | marketbeat.comJSF Financial LLC Makes New Investment in Corcept Therapeutics Incorporated $CORTOctober 5, 2025 | marketbeat.comCorcept Therapeutics (CORT): Evaluating Valuation After New Curant Health Partnership and Pipeline ProgressOctober 4, 2025 | finance.yahoo.comCorcept Therapeutics (NASDAQ:CORT) Insider Sells $423,750.00 in StockOctober 4, 2025 | insidertrades.comCorcept Therapeutics (NASDAQ:CORT) Insider Joseph Douglas Lyon Sells 5,000 SharesOctober 3, 2025 | marketbeat.comCorcept Therapeutics (NASDAQ:CORT) Insider Sells $1,701,200.00 in StockOctober 3, 2025 | marketbeat.comCorcept Therapeutics (NASDAQ:CORT) CEO Sells $3,403,200.00 in StockOctober 3, 2025 | marketbeat.comCorcept Therapeutics (NASDAQ:CORT) Downgraded by Zacks Research to Strong SellOctober 3, 2025 | marketbeat.comSynergy Asset Management LLC Raises Holdings in Corcept Therapeutics Incorporated $CORTOctober 3, 2025 | marketbeat.comCorcept Therapeutics Incorporated (NASDAQ:CORT) Given Average Rating of "Buy" by AnalystsOctober 3, 2025 | marketbeat.comPublic Employees Retirement System of Ohio Boosts Stock Holdings in Corcept Therapeutics Incorporated $CORTOctober 3, 2025 | marketbeat.comWealth Enhancement Advisory Services LLC Buys 5,693 Shares of Corcept Therapeutics Incorporated $CORTOctober 2, 2025 | marketbeat.comWhy Corcept (CORT) Stock Is Trading Up TodayOctober 1, 2025 | msn.comState of Alaska Department of Revenue Raises Position in Corcept Therapeutics Incorporated $CORTSeptember 30, 2025 | marketbeat.comCorcept Therapeutics Beats Q2 Estimates, Cuts Guidance and Advances NDA for New Cancer DrugSeptember 29, 2025 | insidermonkey.comCorcept Therapeutics Incorporated's (NASDAQ:CORT) large institutional owners must be happy as stock continues to impress, up 4.2% over the past weekSeptember 28, 2025 | finance.yahoo.comCorcept Therapeutics (NASDAQ:CORT) Upgraded to "Buy" at Wall Street ZenSeptember 26, 2025 | marketbeat.comCorcept Primed For An Upside EPS SurpriseSeptember 26, 2025 | seekingalpha.com Get Corcept Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CORT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CORT Media Mentions By Week CORT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CORT News Sentiment▼0.850.49▲Average Medical News Sentiment CORT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CORT Articles This Week▼1916▲CORT Articles Average Week Get the Latest News and Ratings for CORT and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Corcept Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Annovis Bio News Today Royalty Pharma News Today Jazz Pharmaceuticals News Today Perrigo News Today Supernus Pharmaceuticals News Today Nektar Therapeutics News Today Pacira BioSciences News Today Omeros News Today Assembly Biosciences News Today Cumberland Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CORT) was last updated on 10/20/2025 by MarketBeat.com Staff From Our PartnersGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredThis Crypto Is Set to Explode in JanuaryCurious about crypto but still stuck scrolling endless threads? People who get in early aren’t just lucky—they...Crypto 101 Media | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAI's Next Magnificent SevenThe original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corcept Therapeutics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Corcept Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
